The One Piece, Netflix‘s anime remake of the original One Piece series, is set to premiere in February 2027, the streamer announced Tuesday. You can see the just-released key art above and full, large ...

Jamf finds a ClickFix variant that swaps copy-paste Terminal lures for Script Editor execution, tightening delivery of Atomic Stealer. ClickFix malware campaigns are evolving again, with threat actors ...

It's hard to be a One Piece fan if you have FOMO. The franchise is the gift that keeps on giving, and there's no shortage of ways to experience it. If Netflix's live-action One Piece show is not ...

In the finale of Season 2, One Piece: Into the Grand Line, Luffy and his Straw Hat crew set sail for Alabasta to help their new friend, Princess Vivi, and her people confront the villainous Baroque ...

The streamer revealed the third season of the main live-action series will be titled 'One Piece: The Battle of Alabasta' and will arrive in 2027. By Abid Rahman International Editor, Digital Straw ...

The concept of Devil Fruit awakening was first introduced in the Dressrosa arc of One Piece, and since then, new characters with awakened powers have shown up often. Elbaf has just introduced fans to ...

Dan Selcke is a pop culture fanatic who writes and talks about movies, TV and books, the nerdier the better. He's been working on news, reviews, editorials, interviews and podcasts for over 10 years.

All eight episodes of One Piece Season 2 premiere March 10 on Netflix. Let's get something out of the way first: There is no need to worry about Tony Tony Chopper, because the beloved doctor of the ...

One Piece season two is bigger, better, and more ambitious in almost every way than its freshman voyage; here’s our review. Welcome back, Straw Hat Nakama! The long-awaited second season of the ...

There is no anime or manga quite like the legendary "One Piece." For nearly 30 years, this manga and anime have delighted readers and viewers with its epic tale of adventure, friendship, and defiance ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...